ARID1A and neoplasm: A smaller cohort of tumours was assessed for CD8+ TILs within the tumour epithelium (933 ENOC and 480 CCOC), with ARID1A loss being associated with statistically significant higher CD8+ TILs in ENOC but not in CCOC, although a trend to higher CD8+ TILs was seen.